Skip to content

Clinical trials

Phase 1 Dwarfism, Pituitary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dwarfism, Pituitary Phase: Phase 1 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20061
20071
20081
20101
20112
20122
20132
20151
20172
20191
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S6
Changchun GeneScience Pharmaceutical Co., Ltd.2
Aileron Therapeutics, Inc.1
Azidus Brasil1
EMD Serono1
HanAll BioPharma Co., Ltd.1
OPKO Health, Inc.1
Oregon Health and Science University1
Phage Pharmaceuticals, Inc.1
Teva Neuroscience, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dwarfism, Pituitary18
Bone Diseases1
Bone Diseases, Developmental1
Bone Diseases, Endocrine1
Brain Concussion1
Brain Diseases1
Dwarfism1
Failure to Thrive1
Hypopituitarism1
Insulin Resistance1

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.